Trachelectomy

Last updated
Trachelectomy
Diagram showing the parts removed with trachelectomy surgery CRUK 338.svg
Diagram showing the parts removed with a trachelectomy
ICD-9-CM 67.4

In gynecologic oncology, trachelectomy, also called cervicectomy, is a surgical removal of the uterine cervix. [1] As the uterine body is preserved, this type of surgery is a fertility preserving surgical alternative to a radical hysterectomy and applicable in selected younger women with early cervical cancer. [2]

Contents

Types

Trachelectomies, broadly, can be divided into the simple and radical variants.

Radical

The formal name of this operation is radical vaginal trachelectomy (RVT) and also known as the Dargent operation and radical trachelectomy.[ citation needed ]

The word radical is used as, in addition to the cervix (like in radical hysterectomies), the parametria (tissue adjacent to the cervix) and vaginal cuff (the end of the vagina close to the cervix) are also excised as a part of the operation. [3] It is usually done with a lymphadenectomy, to assess for tumour spread to the lymph nodes. This operation was pioneered by the renowned French Obstetrician-Gynecologist Surgeon, Daniel Dargent (1937–2005), who performed it for the 1st time in 1993. [4]

Simple

A simple trachelectomy refers to the removal of the cervix; this can be considered to be a very large conization procedure. [5]

Indications

Radical trachelectomy is considered to be the optimal treatment for women of age ≤40 years with a desire to preserve fertility and stage IA2 or mild stage IB1 disease; more specifically, it is deemed appropriate when the disease consists of a tumour less than or equal to 2 cm in largest dimension and has not spread to lymph nodes. [6] However, it is not yet considered the standard of care; hysterectomy is the standard of care. [7]

Conization is considered the standard treatment for less advanced cancers (stage 1A1).

Trachelectomy compared to other treatments

Data on long-term outcomes is limited. However, it appears that cancer recurrence and death are similar when compared to standard treatments (radical hysterectomy and radiation). [8] Death and cancer recurrence rates (associated with the procedure) are approximately 3% and 5% respectively. [9] [10]

Pregnancy post-trachelectomy

Following RVT, approximately 70% of patients that want to have children are able to conceive. [8] However, absence of the cervix increases the risk of miscarriage and preterm delivery. [11] Subsequent delivery is by caesarean section.

See also

Related Research Articles

<span class="mw-page-title-main">Cervical cancer</span> Cancer arising from the cervix

Cervical cancer is a cancer arising from the cervix or in the any layer of the wall of the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Early on, typically no symptoms are seen. Later symptoms may include abnormal vaginal bleeding, pelvic pain or pain during sexual intercourse. While bleeding after sex may not be serious, it may also indicate the presence of cervical cancer.

<span class="mw-page-title-main">Hysterectomy</span> Surgical removal of the uterus

Hysterectomy is the surgical removal of the uterus and cervix. Supracervical hysterectomy refers to removal of the uterus while the cervix is spared. These procedures may also involve removal of the ovaries (oophorectomy), fallopian tubes (salpingectomy), and other surrounding structures. The term “partial” or “total” hysterectomy are lay-terms that incorrectly describe the addition or omission of oophorectomy at the time of hysterectomy. These procedures are usually performed by a gynecologist. Removal of the uterus renders the patient unable to bear children and has surgical risks as well as long-term effects, so the surgery is normally recommended only when other treatment options are not available or have failed. It is the second most commonly performed gynecological surgical procedure, after cesarean section, in the United States. Nearly 68 percent were performed for conditions such as endometriosis, irregular bleeding, and uterine fibroids. It is expected that the frequency of hysterectomies for non-malignant indications will continue to fall given the development of alternative treatment options.

<span class="mw-page-title-main">Endometrial cancer</span> Uterine cancer that is located in tissues lining the uterus

Endometrial cancer is a cancer that arises from the endometrium. It is the result of the abnormal growth of cells that have the ability to invade or spread to other parts of the body. The first sign is most often vaginal bleeding not associated with a menstrual period. Other symptoms include pain with urination, pain during sexual intercourse, or pelvic pain. Endometrial cancer occurs most commonly after menopause.

<span class="mw-page-title-main">Cervical intraepithelial neoplasia</span> Medical condition

Cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia, is the abnormal growth of cells on the surface of the cervix that could potentially lead to cervical cancer. More specifically, CIN refers to the potentially precancerous transformation of cells of the cervix.

<span class="mw-page-title-main">Vaginectomy</span> Surgical removal of the vagina

Vaginectomy is a surgery to remove all or part of the vagina. It is one form of treatment for individuals with vaginal cancer or rectal cancer that is used to remove tissue with cancerous cells. It can also be used in gender-affirming surgery. Some people born with a vagina who identify as trans men or as nonbinary may choose vaginectomy in conjunction with other surgeries to make the clitoris more penis-like (metoidioplasty), construct of a full-size penis (phalloplasty), or create a relatively smooth, featureless genital area.

<span class="mw-page-title-main">Primary peritoneal carcinoma</span> Medical condition

Primary peritoneal cancer or carcinoma is also known as serous surface papillary carcinoma, primary peritoneal carcinoma, extra-ovarian serous carcinoma, primary serous papillary carcinoma, and psammomacarcinoma. It was historically classified under "carcinoma of unknown primary" (CUP). Primary peritoneal cancer is a cancer of the cells lining the peritoneum, or abdominal cavity. It usually affects women and is diagnosed after the age of 60; it very rarely affects men.

<span class="mw-page-title-main">Cardinal ligament</span> Major ligament of the uterus

The cardinal ligament is a major ligament of the uterus formed as a thickening of connective tissue of the base of the broad ligament of the uterus. It extends laterally from the cervix and vaginal fornix to attach onto the lateral wall of the pelvis. The female ureter, uterine artery, and inferior hypogastric (nervous) plexus course within the cardinal ligament. The cardinal ligament supports the uterus.

Gynecologic oncology is a specialized field of medicine that focuses on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. As specialists, they have extensive training in the diagnosis and treatment of these cancers.

Sarcoma botryoides or botryoid sarcoma is a subtype of embryonal rhabdomyosarcoma, that can be observed in the walls of hollow, mucosa lined structures such as the nasopharynx, common bile duct, urinary bladder of infants and young children or the vagina in females, typically younger than age 8. The name comes from the gross appearance of "grape bunches".

Gynecologic cancer is a type of cancer that affects the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer.

<span class="mw-page-title-main">Fallopian tube cancer</span> Medical condition

Primary fallopian tube cancer (PFTC), also known as tubal cancer, is a malignant neoplasm that originates from the fallopian tube. Along with primary ovarian and peritoneal carcinomas, it is grouped under epithelial ovarian cancers; cancers of the ovary that originate from a fallopian tube precursor.

<span class="mw-page-title-main">Uterine serous carcinoma</span> Type of cancer of the uterus

Uterine serous carcinoma is a malignant form of serous tumor that originates in the uterus. It is an uncommon form of endometrial cancer that typically arises in postmenopausal women. It is typically diagnosed on endometrial biopsy, prompted by post-menopausal bleeding.

Neuroendocrine carcinoma of the cervix is best defined separately:Neuroendocrine: Of, relating to, or involving the interaction between the nervous system and the hormones of the endocrine glands.Carcinoma: An invasive malignant tumor derived from epithelial tissue that tends to metastasize to other areas of the body.

<span class="mw-page-title-main">Cervical pregnancy</span> Medical condition

A cervical pregnancy is an ectopic pregnancy that has implanted in the uterine endocervix. Such a pregnancy typically aborts within the first trimester, however, if it is implanted closer to the uterine cavity – a so-called cervico-isthmic pregnancy – it may continue longer. Placental removal in a cervical pregnancy may result in major hemorrhage.

<span class="mw-page-title-main">Clear-cell adenocarcinoma</span> Type of adenocarcinoma that shows clear cells

Clear-cell adenocarcinoma is a rare and aggressive form of cancer that typically arises in the female reproductive organs, particularly the ovaries and the endometrium as well as the kidneys and is characterized by the presence of clear, glycogen-rich cells. Specific criteria must be met for a tumor to be classified as clear cell adenocarcinoma. According to the WHO, these criteria include polygonal or hobnail or cells with clear or eosinophilic/oxyphilic cytoplasm and nuclear atypia, with different architectural patterns of growth, such as papillary, tubulocystic, or solid.

<span class="mw-page-title-main">Uterine adenosarcoma</span> Medical condition

Uterine adenosarcoma is an uncommon form of cancer that arises from mesenchymal tissue of the uterus and has a benign glandular component.

A lymphocele is a collection of lymphatic fluid within the body not bordered by epithelial lining. It is usually a surgical complication seen after extensive pelvic surgery and is most commonly found in the retroperitoneal space. Spontaneous development is rare.

<span class="mw-page-title-main">Wertheim–Meigs operation</span>

The Wertheim–Meigs operation is a surgical procedure for the treatment of cervical cancer performed by way of an abdominal incision.

<span class="mw-page-title-main">Victor Bonney</span>

William Francis Victor Bonney FRCP FRCS was a prominent British gynaecological surgeon. He was described by Geoffrey Chamberlain as "a primary influence on world gynaecology in the years between the wars".

Bradley J. Monk is an American gynecologic oncologist, academician and researcher. He is a professor on the Clinical Scholar Track in the Department of Obstetrics and Gynecology at the University of Arizona College of Medicine in Phoenix, Arizona, as well as at the Creighton University School of Medicine in Omaha, Nebraska. He also serves as Director of the Division of Gynecologic Oncology at the St. Joseph's Hospital and Medical Center in Phoenix.

References

  1. Trachelectomy. baymoon.com. URL: http://www.baymoon.com/~gyncancer/library/glossary/bldeftrachelect.htm Archived 2007-09-27 at the Wayback Machine . Accessed: September 30, 2007.
  2. Dursun P, Ayhan A, Kuscu E (2007). "New surgical approaches for the management of cervical carcinoma". European Journal of Surgical Oncology. 34 (5): 487–96. doi:10.1016/j.ejso.2007.07.012. PMID   17768027.
  3. Tanguay C, Plante M, Renaud MC, Roy M, Têtu B (April 2004). "Vaginal radical trachelectomy in the treatment of cervical cancer: the role of frozen section". Int. J. Gynecol. Pathol. 23 (2): 170–5. doi:10.1097/00004347-200404000-00012. PMID   15084846. S2CID   21653042.
  4. Surbone A, Peccatori F, Pavlidis N (2007-11-09). Cancer and Pregnancy. Springer Science & Business Media. pp. 88–. ISBN   978-3-540-71274-9.
  5. Rob L, Pluta M, Strnad P, et al. (August 2008). "A less radical treatment option to the fertility-sparing radical trachelectomy in patients with stage I cervical cancer". Gynecol. Oncol. 111 (2 Suppl): S116–S120. doi:10.1016/j.ygyno.2008.07.021. PMID   18725167.
  6. Pahisa J, Alonso I, Torné A (September 2008). "Vaginal approaches to fertility-sparing surgery in invasive cervical cancer". Gynecol. Oncol. 110 (3S2): S29–S32. doi:10.1016/j.ygyno.2008.05.005. PMID   18585766.
  7. Ramirez PT, Levenback C (2004). "Radical trachelectomy: is it here to stay?". Gynecol. Oncol. 94 (3): 611–3. doi:10.1016/j.ygyno.2004.07.031. PMID   15350348.
  8. 1 2 Dursun P, LeBlanc E, Nogueira MC (October 2007). "Radical vaginal trachelectomy (Dargent's operation): a critical review of the literature". Eur J Surg Oncol. 33 (8): 933–41. doi:10.1016/j.ejso.2006.11.021. PMID   17208407.
  9. Data. trachelectomy.co.uk. URL:http://www.trachelectomy.co.uk/schedule.htm Archived October 17, 2008, at the Wayback Machine . Accessed on: August 28, 2008.
  10. Beiner ME, Covens A (June 2007). "Surgery insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer". Nat Clin Pract Oncol. 4 (6): 353–61. doi:10.1038/ncponc0822. PMID   17534391. S2CID   8856242.
  11. Jolley JA, Battista L, Wing DA (October 2007). "Management of pregnancy after radical trachelectomy: case reports and systematic review of the literature". Am J Perinatol. 24 (9): 531–9. doi:10.1055/s-2007-986680. PMID   17899494. S2CID   20118144.